EP Patent

EP3075733A1 — Novel heterocyclic compounds and their use in preventing or treating bacterial infections

Assigned to Mutabilis SA · Expires 2016-10-05 · 10y expired

What this patent protects

The present invention relates to heterocyclic compounds, their process of preparation, pharmaceutical compositions comprising these compounds and use thereof, optionally in combination with other antibacterial agents and/or beta-lactam compounds, for the prevention or treatment o…

USPTO Abstract

The present invention relates to heterocyclic compounds, their process of preparation, pharmaceutical compositions comprising these compounds and use thereof, optionally in combination with other antibacterial agents and/or beta-lactam compounds, for the prevention or treatment of bacterial infections. The present invention also relates to the use of these compounds as β-lactamase inhibitors and/or as antibacterial agents.

Drugs covered by this patent

Patent Metadata

Patent number
EP3075733A1
Jurisdiction
EP
Classification
—
Expires
2016-10-05
Drug substance claim
No
Drug product claim
No
Assignee
Mutabilis SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.